Mardi Dier
Directeur Financier/CFO chez MADRIGAL PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/06/2024
Profil
Mme Mardi C. Dier est directrice financière et vice-présidente exécutive d'Ultragenyx Pharmaceutical, Inc. et directrice indépendante d'Oric Pharmaceuticals, Inc. et d'Adamas Pharmaceuticals, Inc. Elle siège aux conseils d'administration de Prelude Therapeutics, Inc. et d'Oric Pharmaceuticals, Inc. et d'Adamas Pharmaceuticals, Inc. Mme Dier a été précédemment employée en tant que directrice financière, directrice des affaires et vice-présidente exécutive chez Portola Pharmaceuticals, Inc. et vice-présidente des relations avec les investisseurs chez Chiron Corp, directrice des services bancaires d'investissement chez Prudential Equity Group LLC, comptable principale chez KPMG LLP, comptable principale chez KPMG Peat Marwick LLP et directrice des services bancaires d'investissement chez Prudential Securities. Elle a également été membre du conseil d'administration de Jewish Vocational Service, Inc. et de Futures Strategic Trust. Elle a obtenu son diplôme de premier cycle à l'université de Stanford et un MBA à l'UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/03/2024 | 8 875 ( 0,04% ) | 2 M $ | 30/06/2024 | |
| 14/06/2024 | 10 000 ( 0,02% ) | 38 100 $ | 30/06/2024 | |
ACELYRIN, INC.
0,01% | 09/05/2023 | 7 306 ( 0,01% ) | 32 219 $ | 30/06/2024 |
ORIC PHARMACEUTICALS INC
-.--% | 12/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Mardi Dier
| Sociétés | Poste | Début |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/03/2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 01/08/2020 |
| MADRIGAL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 11/03/2024 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Consultant / Advisor | - |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 03/06/2021 |
Anciens postes connus de Mardi Dier
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Directeur Financier/CFO | 02/08/2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur Financier/CFO | 15/11/2022 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/06/2021 |
| PORTOLA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/07/2020 |
| ░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mardi Dier
| UCLA Anderson School of Management | Masters Business Admin |
| Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Futures Strategic Trust | Finance |
| KPMG Peat Marwick LLP | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance A unit of Prudential Financial, Inc. (NYSE: PRU), Prudential Equity Group LLC is a broker/dealer headquartered in New York City with additional offices in Chicago, Kansas City, Missouri, Menlo Park, California and San Francisco. The firm provides indpendent equity research, sales and trading to domestic and international institutional clients | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Vocational Service, Inc. operates as a non-profit organization which provides educational and vocational services. It offers education, career services, workforce development, and community services. The company was founded in 1938 and is headquartered in Boston, MA. | Commercial Services |
| Prudential Securities | Finance |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Synthekine, Inc.
Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
